以岭药业董秘吴瑞荣获第六届全景投资者关系金奖“杰出董秘”称号

Group 1 - The sixth Panoramic Investor Relations Gold Award has been announced, with Yiling Pharmaceutical (stock code: 002603) receiving multiple accolades, including "Outstanding Secretary of the Board" for Ms. Wu Rui [1][5] - Yiling Pharmaceutical also won the "Outstanding IR Team" and "Outstanding ESG Value Communication Award," highlighting its strong performance in investor relations [1][5] - Ms. Wu Rui's leadership has established a systematic and standardized investor relations management framework within Yiling Pharmaceutical, earning high recognition from the evaluation panel and the capital market [5] Group 2 - The investor relations team at Yiling Pharmaceutical, under Ms. Wu's guidance, has innovated various management methods, including performance briefings, institutional research, and interactive platforms, fostering positive interactions with investors [5] - The awards are part of a highly influential investor relations management recognition in China, with a committee composed of professionals from regulatory bodies, seasoned secretaries, scholars, economists, and representatives from third-party institutions providing expert evaluation [5]